![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-owner-backs-swiss-biotech-asceneuron-100-million-round-2024-07-16/
https://www.prnewswire.com/news-releases/eqt-life-sciences-invests-in-asceneuron-a-neurodegeneration-therapeutics-company-as-part-of-usd-100-million-series-c-financing-round-302197836.html
https://www.prnewswire.com/news-releases/asceneuron-secures-100-million-series-c-financing-to-advance-groundbreaking-therapeutics-in-neurodegenerative-diseases-302197035.html
https://www.prnewswire.com/news-releases/asceneuron-joins-critical-path-for-alzheimers-disease-consortium-302098497.html
https://www.prnewswire.com/news-releases/asceneuron-expands-scientific-advisory-board-with-world-leading-experts-in-neurodegenerative-diseases-302080344.html
https://www.prnewswire.com/news-releases/industry-veteran-abbas-hussain-appointed-as-chair-of-asceneuron-302016860.html
https://www.prnewswire.com/news-releases/asceneuron-awarded-second-grant-from-the-michael-j-fox-foundation-for-accelerated-research-into-novel-parkinsons-disease-therapies-301538843.html
https://www.prnewswire.com/news-releases/asceneuron-publishes-pioneering-preclinical-efficacy-data-on-its-novel-clinical-molecule-asn90-in-both-alzheimers-and-parkinsons-disease-models-301515705.html